Navigation Links
Gerresheimer Extends Production of Medical Plastic Systems in Bavaria
Date:12/19/2011

DUSSELDORF, Germany, December 19, 2011 /PRNewswire/ --



 

  • Growth in demand for pharmaceutical and medical plastic systems
  • Gerresheimer invests around EUR 25 million in its Pfreimd plant
  • 130 new jobs

 

Gerresheimer AG, one of the world's leading suppliers to the pharma and healthcare industry, further invests in the growth market of complex plastic systems for pharmaceutical and medical applications. Production capacity is being extended at the southern German production facility in Pfreimd at the value of approximately EUR 25 million. High customer demand led to the decision to among other investment to construct a new production hall where medical plastic systems will be manufactured in clean room environments with state-of-the-art injection moulding machines. As a result of this project around 130 new jobs will be created in Pfreimd.

"There has been a sharp increase in demand for medical delivery systems which are simple and safe for patients to use. These include injection systems, insulin pens and inhalers. We are increasing our production capacity so that we can drive future growth in this market," commented Uwe Röhrhoff, CEO of Gerresheimer AG.

The Plastic Systems division is now one of the company's fastest-growing divisions. Gerresheimer Medical Plastic Systems produces insulin pens for diabetics, inhalers for asthma sufferers, lancing devices and disposable laboratory articles for leading pharma and medical technology companies - from the initial design sketches, through tool making and production to packaging and just-in-time delivery.

Inhalers, diabetic supplies such as insulin pens, lancing devices, lancets and disposable laboratory articles are some of the products manufactured in Pfreimd. The plant currently has 550 employees.

Long version of this press release is available at: http://ots.de/AyUB2

Jens Kürten
Director Corporate Communication & Marketing
Telephone  +49-211-6181-250
Fax  +49-211-6181-241
E-Mail  j.kuerten@gerresheimer.com
Internet  http://www.gerresheimer.com



'/>"/>
SOURCE Gerresheimer AG
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Gerresheimer has Passed the Turning Point
2. Gerresheimer Achieves Sales Target for 2009
3. Moodys Raised Outlook for Gerresheimer
4. Substantial Revenues and Earnings Plus for Gerresheimer
5. Gerresheimer Reports Strong Earnings and Sales Growth
6. Gerresheimer Reports Strong Revenues and Earnings Growth in the Second Quarter
7. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
8. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
9. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
10. FDA Extends Review of Genasense(R) NDA Appeal in Chronic Lymphocytic Leukemia
11. Protalix BioTherapeutics Extends Research Agreement With Yissum Based on Promising Acetylcholinesterase Program Results in Animal Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation announce a ... sensors for real-time monitoring of patients with trauma-related and ... focused on disruptive health solutions for rare disorders and ... record and integrate behavioral, cognitive, physiological and contextual data. ... ...
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: ... data solutions, today announced that its MyDario product is expected to appear ... listings for when The Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, The ... ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: ... “America On The Brink” is the creation of published author, William Nowers. ... As a WWII veteran, he spent thirty years in the Navy. Following ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
(Date:10/12/2017)... ... , ... The American College of Medical Informatics (ACMI) will present the 2017 ... Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is ... pioneer in the field of medical informatics, this prestigious award is presented to an ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
Breaking Medicine News(10 mins):